548 related articles for article (PubMed ID: 14581420)
1. Time course and predictors of symptoms after primary prostate cancer therapy.
Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
[TBL] [Abstract][Full Text] [Related]
2. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.
Miller DC; Sanda MG; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin WP; Wei JT
J Clin Oncol; 2005 Apr; 23(12):2772-80. PubMed ID: 15837992
[TBL] [Abstract][Full Text] [Related]
4. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
6. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
Bradley EB; Bissonette EA; Theodorescu D
BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
[TBL] [Abstract][Full Text] [Related]
7. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
Hedgepeth RC; Labo J; Zhang L; Wood DP
J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
[TBL] [Abstract][Full Text] [Related]
8. Complications from treatment for prostate carcinoma among men in the Detroit area.
Schwartz K; Bunner S; Bearer R; Severson RK
Cancer; 2002 Jul; 95(1):82-9. PubMed ID: 12115320
[TBL] [Abstract][Full Text] [Related]
9. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.
Pardo Y; Guedea F; Aguiló F; Fernández P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Craven-Bratle J; Suárez JF; Boladeras A; Pont À; Ayala A; Sancho G; Martínez E; Alonso J; Ferrer M
J Clin Oncol; 2010 Nov; 28(31):4687-96. PubMed ID: 20921463
[TBL] [Abstract][Full Text] [Related]
10. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
[TBL] [Abstract][Full Text] [Related]
11. Patients' perceptions of quality of life after treatment for early prostate cancer.
Clark JA; Inui TS; Silliman RA; Bokhour BG; Krasnow SH; Robinson RA; Spaulding M; Talcott JA
J Clin Oncol; 2003 Oct; 21(20):3777-84. PubMed ID: 14551296
[TBL] [Abstract][Full Text] [Related]
12. Quality of life outcomes after brachytherapy for early stage prostate cancer.
Brandeis JM; Litwin MS; Burnison CM; Reiter RE
J Urol; 2000 Mar; 163(3):851-7. PubMed ID: 10687991
[TBL] [Abstract][Full Text] [Related]
13. Defining sexual outcomes after treatment for localized prostate carcinoma.
Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
[TBL] [Abstract][Full Text] [Related]
14. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
Glickman L; Godoy G; Lepor H
J Urol; 2009 Feb; 181(2):731-5. PubMed ID: 19091349
[TBL] [Abstract][Full Text] [Related]
15. Treatment 'mismatch' in early prostate cancer: do treatment choices take patient quality of life into account?
Chen RC; Clark JA; Manola J; Talcott JA
Cancer; 2008 Jan; 112(1):61-8. PubMed ID: 18040996
[TBL] [Abstract][Full Text] [Related]
16. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study.
Penson DF; McLerran D; Feng Z; Li L; Albertsen PC; Gilliland FD; Hamilton A; Hoffman RM; Stephenson RA; Potosky AL; Stanford JL
J Urol; 2005 May; 173(5):1701-5. PubMed ID: 15821561
[TBL] [Abstract][Full Text] [Related]
17. Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function.
Chen RC; Clark JA; Talcott JA
J Clin Oncol; 2009 Aug; 27(24):3916-22. PubMed ID: 19620493
[TBL] [Abstract][Full Text] [Related]
18. Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results.
Borchers H; Kirschner-Hermanns R; Brehmer B; Tietze L; Reineke T; Pinkawa M; Eble MJ; Jakse G
BJU Int; 2004 Oct; 94(6):805-11. PubMed ID: 15476513
[TBL] [Abstract][Full Text] [Related]
19. Impact of nerve sparing technique on patient self-assessed outcomes after radical perineal prostatectomy.
Kübler HR; Tseng TY; Sun L; Vieweg J; Harris MJ; Dahm P
J Urol; 2007 Aug; 178(2):488-92; discussion 492. PubMed ID: 17561133
[TBL] [Abstract][Full Text] [Related]
20. Sex or surgery--erectile dysfunction after radical treatment of localized prostate cancer.
Kelović VL; Buković D; Badzek S; Curić Z; Kelović Z; Persec Z; Pavić M
Coll Antropol; 2009 Jun; 33(2):529-32. PubMed ID: 19662774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
